DFDA

Activity Pacing / Energy Management

Treatment for Chronic Fatigue Syndrome

Typical Dosage: Individualized, e.g., managing activity within individual energy envelope, taking regular rest breaks

Effectiveness
65%
Safety Score
95%
Clinical Trials
30
Participants
3K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
95
DangerousModerateSafe
Treatment Details
Dosage Range
Individualized, e.g., managing activity within individual energy envelope, taking regular rest breaks
Time to Effect
1-3 months
Treatment Duration
Lifetime
Evidence Quality
MODERATE
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,000
Side Effect Mgmt:$0
Total Annual:$1,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
0.1
Outcome-Based Costs
Cost per Responder
$154
Cost per Remission
$3,333
Activity Pacing / Energy Management Outcomes

for Chronic Fatigue Syndrome

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+65%
Remission Rate
+3%
Common Side Effects
Frustration
+5%
Social isolation
+3%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Activity Pacing / Energy Management in Chronic Fatigue Syndrome

Fatigue in Long COVID

NCT07697261NOT YET RECRUITINGNA
View Study
100 participants
INTERVENTIONAL
Started: Nov 1, 2026
Completed Clinical Trials
1 completed trial for Activity Pacing / Energy Management in Chronic Fatigue Syndrome

Effects of a Rehabilitation Programme Focused on Energy Management in People With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

NCT07363655COMPLETEDNA
View Study
13 participants
INTERVENTIONAL
Oliveira de AzemΓ©is, Portugal
Started: Oct 9, 2024